Cargando…
Tumor-Associated Macrophages and Ovarian Cancer: Implications for Therapy
SIMPLE SUMMARY: Ovarian cancer is a highly lethal female malignancy with high rates of advanced stage and recurrent disease. Ovarian cancer is characterized as poorly responsive to immunotherapy. This is hypothesized to be secondary to its highly immunosuppressive and phenotypically “cold” tumor mic...
Autores principales: | Schweer, David, McAtee, Annabel, Neupane, Khaga, Richards, Christopher, Ueland, Frederick, Kolesar, Jill |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101750/ https://www.ncbi.nlm.nih.gov/pubmed/35565348 http://dx.doi.org/10.3390/cancers14092220 |
Ejemplares similares
-
Human macrophage-engineered vesicles for utilization in ovarian cancer treatment
por: Schweer, David, et al.
Publicado: (2023) -
Mithramycin and Analogs for Overcoming Cisplatin Resistance in Ovarian Cancer
por: Schweer, David, et al.
Publicado: (2021) -
SYNE1 Mutation Is Associated with Increased Tumor Mutation Burden and Immune Cell Infiltration in Ovarian Cancer
por: Harbin, Laura M., et al.
Publicado: (2023) -
Dendritic Cell Membrane-Derived Nanovesicles for Targeted
T Cell Activation
por: Harvey, Brock T., et al.
Publicado: (2022) -
Macrophage-Engineered Vesicles for Therapeutic Delivery
and Bidirectional Reprogramming of Immune Cell Polarization
por: Neupane, Khaga R., et al.
Publicado: (2021)